Last reviewed · How we verify
NCT01938898: NICOLA-RT
The NICOLA Recruitment Trial (NICOLA-RT)
NA trial testing Invitation letter randomisation in Healthy Cohort in 13,000 participants. Completed in 20 December 2016.
20 December 2015
Quick facts
| Lead sponsor | Queen's University, Belfast |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | other |
| Enrollment | 13,000 |
| Start date | 1 January 2014 |
| Primary completion | 20 December 2015 |
| Estimated completion | 20 December 2016 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Invitation letter randomisation
Conditions studied
- Healthy Cohort — all drugs for Healthy Cohort →
Sponsor
Queen's University, Belfast
Who can join
50 and older, any sex, with Healthy Cohort. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) is an opportunity to conduct methodology research relevant to many features of a large prospective study. NICOLA will begin in earnest in Northern Ireland in 2013 and is being conducted by a multidisciplinary team in the Centre for Public Health at Queen's University Belfast. It is an omnibus programme of research on ageing that will continue for at least 10 years and will recruit 8500 middle-aged people in Northern Ireland and follow them into old age, providing a comprehensive assessment of their physical and mental health, their lifestyles, and their social and economic decision making. NICOLA will look at how they perceive disability and health, and how this differs between well-off and disadvantaged groups. NICOLA will also study various genetic, biological and psychological factors, including how participants perceive risk and value their time, and the effect of this on their retirement behaviour (including how they manage their money and their health). People over the age of 50 will be invited to take part and asked to complete detailed interviews and questionnaires every 2 years and health assessments every 4 years. The overall aim of this research is to examine the impact of differing invitation letters offered to participants on study recruitment rates.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Dietary patterns associated with renal impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).
Paterson EN, Neville CE, Wallace SM, Woodside JV, et al · · 2021 · cited 6× · PMID 33959803 · DOI 10.1007/s00394-021-02579-z -
The NICOLA recruitment trial (NICOLA-RT): can you improve recruitment by making zero cost amendments to the invitation letter?
Maguire L, Burns F, Clarke M. · · 2015
Verify or expand the search:
- PubMed search for NCT01938898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Queen's University, Belfast trials
Trials by the same sponsor.
- NCT07373041 — Heart Failure Carer Support Programme: Implementation Testing in the UK. · NA · not yet recruiting
- NCT07482839 — Feasibility Study of a Compassionate Mindful Resilience (CMR) Intervention to Improve Mental Health Well-being Outcomes · NA · not yet recruiting
- NCT07333924 — Randomised Study Within a Review (SWAR) to Compare Communication of the Findings of Systematic Reviews to the Public by · Phase 3 · completed
- NCT06896799 — Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM) · NA · recruiting
- NCT06749327 — Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01938898 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen's University, Belfast
- Last refreshed: 11 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01938898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing